Medicines, 2023
Shortlist up to four to read them side by side.
1,252 medicine recalls FDA’s Enforcement Report published in 2023, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 6, 2026.
1,252of 1,252 medicine recallsshown with your filters
The list
- Medicine recall Glimepiride 2 mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropinirole 0.5 mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Rosuvastatin 5mg tablets, 30-count bottles cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin 10 mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Tadalafil 5 mg tablets, 30-count bottles cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Atorvastatin 20 mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropinirole 2mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Rosuvastatin 5mg tablets, 30-count bottles cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Rosuvastatin 10mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Rosuvastatin 40mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin 40 mg tablets cGMP Deviations Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprazolam Tab, USP 0.5mg, (CIV) CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprazolam Tab, USP 1mg, (CIV) CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprazolam C-IV, 0.5 mg, 30 Tabs per bottle CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Alprazolam C-IV, 1 mg CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Alprazolam C-IV, 2 mg, 60 Tabs per bottle CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Montelukast Sodium Oral Granules USP, 4 mg Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A. Class IIIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Atorvastatin Calcium Tablets, USP, 10 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Atorvastatin Calcium Tablets, USP, 20 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Clopidogrel Tablets USP, 75 mg, 90-count bottles cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Doxazosin Tablets, USP, 2 mg, 100-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Doxazosin Tablets, USP, 4 mg, 100-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Finasteride Tablets, USP, 5 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Glimepiride Tablets, USP, 2 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Montelukast Sodium Tablets, USP, 10 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Rosuvastatin Tablets, USP, 10 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Rosuvastatin Tablets, USP, 5mg, 30-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Pravastatin Sodium Tablets, USP, 20 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Simvastatin Tablets, USP, 10 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Simvastatin Tablets, USP, 80 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Simvastatin Tablets, USP, 20 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Simvastatin Tablets, USP, 40 mg cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Tadalafil Tablets, USP, 20 mg, 7-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Glimepiride Tablets USP, 4 mg, 90-count bottle cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection. Class IIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular… Sub-potent drug: assay test result below specifications at 9-month timepoint. Class IIIFDA’s classApr 12, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 12, 2023ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International… Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of… Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Montelukast Sodium Tablets, USP, 10 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Finasteride, USP, 5 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropinirole, USP, 0.25 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Ropinirole, USP, 1 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glimepiride, USP, 1 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glimepiride, USP, 2 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Glimepiride, USP, 4 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin, USP, 5 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin, USP, 10 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin, USP, 20 mg Tablets cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Simvastatin, USP, 40 mg cGMP deviations Class IIFDA’s classApr 5, 2023in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedApr 5, 2023ClassClass IIStatusTerminatedWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.